http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010049236-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a0c49e5390c69aa92b87c3a892344c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate | 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c20ac14a1705671bf79bdb7da15d9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d1b4cebd969e5dad0b2fb4eba0b0f4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd3e466c93414561227f48754f4f036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebef995a0b239ab9af5b791d49506d76 |
| publicationDate | 2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2010049236-A1 |
| titleOfInvention | Method for testing an agent for strokes in humans with a non-human stroke model |
| abstract | An agent for treating strokes in humans is tested in a non-human subject by selecting an agent for testing and by preparing a selected non-human subject. The preparation includes: inducing a stroke event by advancing a microwire through the arterial system of the subject to a selected intracranial target position, inserting a microcatheter along the microwire and delivering an embolic device to the target position, occluding the artery at the target position by deploying the embolic device, verifying the occlusion and repositioning the embolic device if needed. After a predetermined occlusion interval, reperfusion of the subject is simulated by removing the embolic device and commencing therapy with the selected agent. At appropriate intervals, the effect of the conducted course of therapy is assessed non-invasively until terminal evaluation. In particular aspects, the method involves occluding the middle cerebral artery through an access achieved via the basilar artery. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3243516-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014172266-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3427735-A1 |
| priorityDate | 2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.